MARKET RADAR
SENSEX     NIFTY      Refresh
Transgene Biotek
BSE: 526139|ISIN: INE773D01018|SECTOR: Hospitals & Medical Services
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 28, 17:00
28.60
0.25 (0.88%)
VOLUME 183,874
Transgene Biotek is not listed on NSE
Announcements on Transgene Biote

24th-May-2012 15:19Source: BSE

Transgene Biote- Transgene reports excellent results from TrabiOral oral insulin studies

Transgene Biotek Ltd has informed BSE regarding "Transgene reports excellent results from TrabiOral oral insulin studies".

27th-Apr-2012 10:53Source: BSE

Transgene Biote- Transgene Biotek continues its forey westwards

Transgene Biotek Ltd has informed BSE regarding a Press Release dated April 27, 2012, titled "Transgene Biotek continues its forey westwards".

22nd-Mar-2012 19:35Source: BSE

Transgene Biote- Change in Compliance Officer

Transgene Biotek Ltd has informed BSE that Mr. C Ramakrishna has been appointed as the new Compliance officer of the company with immediate effect.

23rd-Feb-2012 18:48Source: BSE

Transgene Biote- Limited Review for Dec 31, 2011

Transgene Biotek Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2011.

15th-Feb-2012 19:26Source: BSE

Transgene Biote- Financial Results for Dec 31, 2011

Transgene Biotek Ltd has informed BSE about the Financial Results for the period ended December 31, 2011.

23rd-Nov-2011 08:58Source: BSE

Transgene Biote- Sale of Technology by Transgene

Transgene Biotek Ltd has submitted to BSE an announcement on Sale of Technology by Transgene, dated November 23, 2011.

Announcement:

"The management of Transgene has formalized the sale...

15th-Nov-2011 19:46Source: BSE

Transgene Biote- Financial Results for Sep 30, 2011

Transgene Biotek Ltd has informed BSE about the Financial Results for the period ended September 30, 2011.

10th-Oct-2011 11:17Source: BSE

Transgene Biote- Transgene Biotek commences commercial production of DHA

Transgene Biotek Ltd has informed BSE regarding "Transgene Biotek commences commercial production of DHA"

4th-Oct-2011 08:17Source: BSE

Transgene Biote- Outcome of Board Meeting - Issue of GDRs

Transgene Biotek Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 03, 2011, has allotted 2,500,000 GDRs underlying 25,000,000 Equity Shares of Rs. 10/- ea...

3rd-Oct-2011 08:57Source: BSE

Transgene Biote- Outcome of AGM

Transgene Biotek Ltd has informed BSE that the members at the 21st Annual General Meeting (AGM) of the Company held on September 30, 2011, inter alia, have passed the following resolutions:

- O...

1 2 3 4 5 Next >>
Board Meeting (Transgene Biote)

Meeting Date

Remark

2012-05-30

Quarterly Results

Quick Links for Transgene Biotek
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.